We were particularly intrigued to investigate the potential link between incretin-based drugs, such as DPP-4 inhibitors and GLP-1RAs, and pancreatic cancer
Anyone starting a compounded GLP-1 program in mid-2026 should discuss the regulatory transition with their clinical provider and plan for potential changes in medication availability
However, a person should follow individualized advice when vomiting, diabetes, kidney disease, or malnutrition complicates the situation
What is the Rybelsus vision loss lawsuit about
To manage the patients chief complaint, she was started on pilocarpine 5 mg/day
It can be considered a nutrient as well as a dietary supplement, as it is formed from the amino acid lysine